149 related articles for article (PubMed ID: 11181174)
41. The human T-cell leukemia virus type-1 tax oncoprotein dissociates NF-κB p65
Malu A; Hutchison T; Yapindi L; Smith K; Nelson K; Bergeson R; Pope J; Romeo M; Harrod C; Ratner L; Van Lint C; Harrod R
Virology; 2019 Sep; 535():83-101. PubMed ID: 31299491
[TBL] [Abstract][Full Text] [Related]
42. Mutations of oncoprotein 18/stathmin identify tubulin-directed regulatory activities distinct from tubulin association.
Larsson N; Segerman B; Gradin HM; Wandzioch E; Cassimeris L; Gullberg M
Mol Cell Biol; 1999 Mar; 19(3):2242-50. PubMed ID: 10022911
[TBL] [Abstract][Full Text] [Related]
43. Role of the microtubule destabilizing proteins SCG10 and stathmin in neuronal growth.
Grenningloh G; Soehrman S; Bondallaz P; Ruchti E; Cadas H
J Neurobiol; 2004 Jan; 58(1):60-9. PubMed ID: 14598370
[TBL] [Abstract][Full Text] [Related]
44. The 4 A X-ray structure of a tubulin:stathmin-like domain complex.
Gigant B; Curmi PA; Martin-Barbey C; Charbaut E; Lachkar S; Lebeau L; Siavoshian S; Sobel A; Knossow M
Cell; 2000 Sep; 102(6):809-16. PubMed ID: 11030624
[TBL] [Abstract][Full Text] [Related]
45. Resistance to microtubule-targeted cytotoxins in a K562 leukemia cell variant associated with altered tubulin expression and polymerization.
Dumontet C; Jaffrezou JP; Tsuchiya E; Duran GE; Chen KG; Derry WB; Wilson L; Jordan MA; Sikic BI
Bull Cancer; 2004 May; 91(5):E81-112. PubMed ID: 15568225
[TBL] [Abstract][Full Text] [Related]
46. Control of microtubule dynamics by oncoprotein 18: dissection of the regulatory role of multisite phosphorylation during mitosis.
Larsson N; Marklund U; Gradin HM; Brattsand G; Gullberg M
Mol Cell Biol; 1997 Sep; 17(9):5530-9. PubMed ID: 9271428
[TBL] [Abstract][Full Text] [Related]
47. Stathmin and microtubules regulate mitotic entry in HeLa cells by controlling activation of both Aurora kinase A and Plk1.
Silva VC; Cassimeris L
Mol Biol Cell; 2013 Dec; 24(24):3819-31. PubMed ID: 24152729
[TBL] [Abstract][Full Text] [Related]
48. Stathmin-deficient mice develop an age-dependent axonopathy of the central and peripheral nervous systems.
Liedtke W; Leman EE; Fyffe RE; Raine CS; Schubart UK
Am J Pathol; 2002 Feb; 160(2):469-80. PubMed ID: 11839567
[TBL] [Abstract][Full Text] [Related]
49. Synergistic antiangiogenic effects of stathmin inhibition and taxol exposure.
Mistry SJ; Bank A; Atweh GF
Mol Cancer Res; 2007 Aug; 5(8):773-82. PubMed ID: 17670914
[TBL] [Abstract][Full Text] [Related]
50. Stathmin destabilizing microtubule dynamics promotes malignant potential in cancer cells by epithelial-mesenchymal transition.
Lu Y; Liu C; Xu YF; Cheng H; Shi S; Wu CT; Yu XJ
Hepatobiliary Pancreat Dis Int; 2014 Aug; 13(4):386-94. PubMed ID: 25100123
[TBL] [Abstract][Full Text] [Related]
51. Phosphorylation regulates the microtubule-destabilizing activity of stathmin and its interaction with tubulin.
Di Paolo G; Antonsson B; Kassel D; Riederer BM; Grenningloh G
FEBS Lett; 1997 Oct; 416(2):149-52. PubMed ID: 9369201
[TBL] [Abstract][Full Text] [Related]
52. Regulation of microtubule destabilizing activity of Op18/stathmin downstream of Rac1.
Wittmann T; Bokoch GM; Waterman-Storer CM
J Biol Chem; 2004 Feb; 279(7):6196-203. PubMed ID: 14645234
[TBL] [Abstract][Full Text] [Related]
53. A centrosomal protein STARD9 promotes microtubule stability and regulates spindle microtubule dynamics.
Srivastava S; Panda D
Cell Cycle; 2018; 17(16):2052-2068. PubMed ID: 30160609
[TBL] [Abstract][Full Text] [Related]
54. Rab11 endosomes contribute to mitotic spindle organization and orientation.
Hehnly H; Doxsey S
Dev Cell; 2014 Mar; 28(5):497-507. PubMed ID: 24561039
[TBL] [Abstract][Full Text] [Related]
55. A synergistic relationship between three regions of stathmin family proteins is required for the formation of a stable complex with tubulin.
Jourdain I; Lachkar S; Charbaut E; Gigant B; Knossow M; Sobel A; Curmi PA
Biochem J; 2004 Mar; 378(Pt 3):877-88. PubMed ID: 14670078
[TBL] [Abstract][Full Text] [Related]
56. Dissociation of the tubulin-sequestering and microtubule catastrophe-promoting activities of oncoprotein 18/stathmin.
Howell B; Larsson N; Gullberg M; Cassimeris L
Mol Biol Cell; 1999 Jan; 10(1):105-18. PubMed ID: 9880330
[TBL] [Abstract][Full Text] [Related]
57. The stathmin/tubulin interaction in vitro.
Curmi PA; Andersen SS; Lachkar S; Gavet O; Karsenti E; Knossow M; Sobel A
J Biol Chem; 1997 Oct; 272(40):25029-36. PubMed ID: 9312110
[TBL] [Abstract][Full Text] [Related]
58. Low potency of taxol at microtubule minus ends: implications for its antimitotic and therapeutic mechanism.
Derry WB; Wilson L; Jordan MA
Cancer Res; 1998 Mar; 58(6):1177-84. PubMed ID: 9515803
[TBL] [Abstract][Full Text] [Related]
59. Characterization and detection of cellular and proteomic alterations in stable stathmin-overexpressing, taxol-resistant BT549 breast cancer cells using offgel IEF/PAGE difference gel electrophoresis.
Balasubramani M; Nakao C; Uechi GT; Cardamone J; Kamath K; Leslie KL; Balachandran R; Wilson L; Day BW; Jordan MA
Mutat Res; 2011 Jun; 722(2):154-64. PubMed ID: 20816848
[TBL] [Abstract][Full Text] [Related]
60. Selective Inhibition of Spindle Microtubules by a Tubulin-Binding Quinazoline Derivative.
Sawada JI; Ishii H; Matsuno K; Sato M; Suzuki Y; Asai A
Mol Pharmacol; 2019 Nov; 96(5):609-618. PubMed ID: 31471455
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
